- Home
- FTEL vs BOLT Comparison
FTEL vs BOLT Comparison
Compare FTEL & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTEL
- BOLT
- Stock Information
- Founded
- FTEL 2007
- BOLT 2015
- Country
- FTEL Australia
- BOLT United States
- Employees
- FTEL N/A
- BOLT N/A
- Industry
- FTEL
- BOLT Biotechnology: Pharmaceutical Preparations
- Sector
- FTEL
- BOLT Health Care
- Exchange
- FTEL Nasdaq
- BOLT Nasdaq
- Market Cap
- FTEL 9.1M
- BOLT 9.4M
- IPO Year
- FTEL 2023
- BOLT 2021
- Fundamental
- Price
- FTEL $0.59
- BOLT $5.18
- Analyst Decision
- FTEL
- BOLT Buy
- Analyst Count
- FTEL 0
- BOLT 3
- Target Price
- FTEL N/A
- BOLT $47.50
- AVG Volume (30 Days)
- FTEL 142.6K
- BOLT 12.6K
- Earning Date
- FTEL 04-28-2025
- BOLT 11-11-2025
- Dividend Yield
- FTEL N/A
- BOLT N/A
- EPS Growth
- FTEL N/A
- BOLT N/A
- EPS
- FTEL N/A
- BOLT N/A
- Revenue
- FTEL $4,990,695.00
- BOLT $4,167,000.00
- Revenue This Year
- FTEL N/A
- BOLT N/A
- Revenue Next Year
- FTEL N/A
- BOLT N/A
- P/E Ratio
- FTEL N/A
- BOLT N/A
- Revenue Growth
- FTEL 29.02
- BOLT N/A
- 52 Week Low
- FTEL $0.36
- BOLT $4.59
- 52 Week High
- FTEL $49.50
- BOLT $14.36
- Technical
- Relative Strength Index (RSI)
- FTEL 61.01
- BOLT 47.14
- Support Level
- FTEL $0.39
- BOLT $5.00
- Resistance Level
- FTEL $0.68
- BOLT $5.50
- Average True Range (ATR)
- FTEL 0.06
- BOLT 0.23
- MACD
- FTEL 0.02
- BOLT 0.04
- Stochastic Oscillator
- FTEL 68.51
- BOLT 53.69
About FTEL Fitell Corporation
Fitell Corp engages in primary operations of selling gym and fitness equipment in Australia through its indirectly held wholly owned subsidiaries. It operates in two segments: online fitness equipment distribution and licensing business to service the large and growing boutique fitness sector of the broader health and fitness club industry. The majority fitness equipment business is conducted in Australia via its own e-commerce platform and, through third-party sites. Licensing service offers a turnkey solution for personal training studios and commercial gym chains. The company earns maximum of revenue for retail.
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.